Pharsight

Drugs that contain Phentolamine Mesylate

1. Oraverse patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6872390 SEPTODONT HOLDING Local anesthetic methods and kits
May, 2021

(2 years ago)

US6764678 SEPTODONT HOLDING Local anesthetic methods and kits
May, 2021

(2 years ago)

US7575757 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Jul, 2023

(8 months ago)

US7229630 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Jul, 2023

(8 months ago)

US7569230 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
Oct, 2023

(6 months ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Mar 18, 2019

Market Authorisation Date: 09 May, 2008

Treatment: A method of reversing soft-tissue anesthesia i.e. anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic

Dosage: INJECTABLE;INJECTION

More Information on Dosage

ORAVERSE family patents

Family Patents